Skip to content

Clinical trials

Phase 2 Inflammation trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20101
20111
20122
20131
20151
20163
20181
20191
20202
20222
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated7
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Novo Nordisk A/S3
InflaRx GmbH2
Novartis Pharmaceuticals2
Amgen1
Centocor, Inc.1
Charite University, Berlin, Germany1
Inmune Bio, Inc.1
Janssen Research & Development, LLC1
Martin-Luther-Universität Halle-Wittenberg1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation20
Arthritis, Rheumatoid4
Crohn Disease2
Pulmonary Disease, Chronic Obstructive2
Alzheimer Disease1
Anemia1
Asthma1
Autoimmune Diseases1
Brain Diseases1
Bronchitis, Chronic1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.